Organoids Model Transcriptional Hallmarks of Oncogenic KRAS Activation in Lung Epithelial Progenitor Cells.

KRAS alveolar developmental programs early-stage lung cancer iPSC loss of differentiation organoid single-cell RNA sequencing stage IA lung adenocarcinoma tumor progression

Journal

Cell stem cell
ISSN: 1875-9777
Titre abrégé: Cell Stem Cell
Pays: United States
ID NLM: 101311472

Informations de publication

Date de publication:
01 10 2020
Historique:
received: 26 05 2020
revised: 09 07 2020
accepted: 29 07 2020
pubmed: 7 9 2020
medline: 28 4 2021
entrez: 6 9 2020
Statut: ppublish

Résumé

Mutant KRAS is a common driver in epithelial cancers. Nevertheless, molecular changes occurring early after activation of oncogenic KRAS in epithelial cells remain poorly understood. We compared transcriptional changes at single-cell resolution after KRAS activation in four sample sets. In addition to patient samples and genetically engineered mouse models, we developed organoid systems from primary mouse and human induced pluripotent stem cell-derived lung epithelial cells to model early-stage lung adenocarcinoma. In all four settings, alveolar epithelial progenitor (AT2) cells expressing oncogenic KRAS had reduced expression of mature lineage identity genes. These findings demonstrate the utility of our in vitro organoid approaches for uncovering the early consequences of oncogenic KRAS expression. This resource provides an extensive collection of datasets and describes organoid tools to study the transcriptional and proteomic changes that distinguish normal epithelial progenitor cells from early-stage lung cancer, facilitating the search for targets for KRAS-driven tumors.

Identifiants

pubmed: 32891189
pii: S1934-5909(20)30360-X
doi: 10.1016/j.stem.2020.07.022
pmc: PMC7541765
mid: NIHMS1619122
pii:
doi:

Substances chimiques

KRAS protein, human 0
Proto-Oncogene Proteins p21(ras) EC 3.6.5.2

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

663-678.e8

Subventions

Organisme : NHLBI NIH HHS
ID : R01 HL128172
Pays : United States
Organisme : NHLBI NIH HHS
ID : U01 HL134745
Pays : United States
Organisme : NCI NIH HHS
ID : U01 CA196408
Pays : United States
Organisme : NHLBI NIH HHS
ID : U01 HL134766
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL122442
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL095993
Pays : United States
Organisme : NHLBI NIH HHS
ID : R35 HL150876
Pays : United States

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Interests W.D.W. is a member of the Leica Biosystems Medical Imaging Advisory Board. S.M.D. is on the Scientific Advisory Boards of EarlyDiagnostics; Johnson & Johnson Lung Cancer Initiative; LungLife AI; and T-Cure Bioscience. He has received research funding from Johnson & Johnson Lung Cancer Initiative and Novartis. C.F.K. has a sponsored research agreement from Celgene/BMS, but this funding did not support the research described in this manuscript.

Références

Nature. 2018 Aug;560(7719):494-498
pubmed: 30089906
Cell Stem Cell. 2017 Oct 5;21(4):472-488.e10
pubmed: 28965766
J Exp Clin Cancer Res. 2012 Mar 03;31:18
pubmed: 22385677
Dev Cell. 2008 Jun;14(6):818-29
pubmed: 18539112
Nat Methods. 2018 Apr;15(4):255-261
pubmed: 29481549
Nucleic Acids Res. 2020 Jan 8;48(D1):D1145-D1152
pubmed: 31686107
Nat Commun. 2019 Sep 5;10(1):3991
pubmed: 31488816
Cell. 2017 Sep 7;170(6):1149-1163.e12
pubmed: 28886383
Cells Tissues Organs. 2013;198(1):12-21
pubmed: 23774755
Nature. 2009 Nov 5;462(7269):104-7
pubmed: 19847165
Nature. 2020 Nov;587(7835):619-625
pubmed: 33208946
Physiol Rev. 2007 Jan;87(1):219-44
pubmed: 17237346
Cancer Res. 2005 Nov 15;65(22):10280-8
pubmed: 16288016
Signal Transduct Target Ther. 2018 Feb 23;3:5
pubmed: 29527331
Nat Genet. 2019 Apr;51(4):728-738
pubmed: 30778223
Mol Syst Biol. 2019 Dec;15(12):e9021
pubmed: 31885202
Nat Biotechnol. 2010 May;28(5):511-5
pubmed: 20436464
Stem Cell Rev Rep. 2009 Sep;5(3):224-30
pubmed: 19551524
Cell. 2005 Jun 17;121(6):823-35
pubmed: 15960971
Cell. 2006 Aug 25;126(4):663-76
pubmed: 16904174
Proc Natl Acad Sci U S A. 2010 May 25;107(21):9546-51
pubmed: 20460310
Cell Stem Cell. 2010 Jul 2;7(1):127-33
pubmed: 20621056
Nature. 2011 May 5;473(7345):101-4
pubmed: 21471965
Nat Med. 2020 Feb;26(2):259-269
pubmed: 32042191
Nature. 2006 Jan 19;439(7074):353-7
pubmed: 16273092
Database (Oxford). 2019 Jan 1;2019:
pubmed: 30951143
Genes (Basel). 2017 May 13;8(5):
pubmed: 28505071
Nature. 2014 Jul 31;511(7511):543-50
pubmed: 25079552
Genome Biol. 2014;15(12):550
pubmed: 25516281
Cancer Cell. 2004 Apr;5(4):375-87
pubmed: 15093544
Nature. 2017 May 18;545(7654):355-359
pubmed: 28489818
Science. 2013 Nov 8;342(6159):1234850
pubmed: 24202173
EMBO J. 2019 Feb 15;38(4):
pubmed: 30643021
Trends Cancer. 2017 Oct;3(10):686-697
pubmed: 28958387
Genome Biol. 2018 Feb 6;19(1):15
pubmed: 29409532
BMC Bioinformatics. 2018 Apr 12;19(1):135
pubmed: 29649993
Dev Cell. 2015 Nov 9;35(3):322-32
pubmed: 26555052
Genome Biol. 2019 Dec 23;20(1):296
pubmed: 31870423
PLoS Genet. 2019 Nov 1;15(11):e1008432
pubmed: 31675358
Cell. 2018 Jul 26;174(3):716-729.e27
pubmed: 29961576
Cell. 2014 Jan 30;156(3):440-55
pubmed: 24485453
Nucleic Acids Res. 2019 Jan 8;47(D1):D33-D38
pubmed: 30204897
Ann Appl Stat. 2016 Jun;10(2):946-963
pubmed: 28367255
Nat Protoc. 2009;4(7):1064-72
pubmed: 19561589
Pharmacogenomics. 2014 Aug;15(11):1507-18
pubmed: 25303301
J Proteome Res. 2011 Apr 1;10(4):1794-805
pubmed: 21254760
BMC Biol. 2014 Mar 24;12:21
pubmed: 24661562
J Clin Lab Anal. 2020 Jan;34(1):e23031
pubmed: 31713908
Cell Stem Cell. 2017 Jun 1;20(6):844-857.e6
pubmed: 28366587
Dev Cell. 2010 Jan 19;18(1):8-23
pubmed: 20152174
Proc Natl Acad Sci U S A. 2012 Mar 27;109(13):4910-5
pubmed: 22411819
Nature. 2018 Mar 8;555(7695):251-255
pubmed: 29489752
Nature. 2009 Nov 5;462(7269):108-12
pubmed: 19847166
Cell Stem Cell. 2018 Mar 1;22(3):454-467.e6
pubmed: 29337182
Nature. 2015 May 7;521(7550):43-7
pubmed: 25924068
Nucleic Acids Res. 2019 Jan 8;47(D1):D442-D450
pubmed: 30395289
Nat Rev Cancer. 2002 Jun;2(6):442-54
pubmed: 12189386
Nat Protoc. 2019 Dec;14(12):3303-3332
pubmed: 31732721
Cell. 2012 Mar 30;149(1):22-35
pubmed: 22464321
Nat Med. 2014 Jul;20(7):769-77
pubmed: 24859528
Elife. 2017 Jun 30;6:
pubmed: 28665271
Cancer Lett. 2011 Aug 28;307(2):191-9
pubmed: 21536374
Nat Commun. 2014 May 29;5:3923
pubmed: 24879355
EMBO J. 2014 Mar 3;33(5):468-81
pubmed: 24497554
Cancers (Basel). 2019 Apr 29;11(5):
pubmed: 31032816
Bioinformatics. 2013 Jan 1;29(1):15-21
pubmed: 23104886
Stem Cell Res. 2014 May;12(3):630-7
pubmed: 24631742
Nucleic Acids Res. 2018 Jan 4;46(D1):D380-D386
pubmed: 29087512
Stem Cell Reports. 2015 Nov 10;5(5):918-931
pubmed: 26455413
Cell. 2019 Jun 13;177(7):1888-1902.e21
pubmed: 31178118
Exp Biol Med (Maywood). 2016 Jun;241(11):1159-68
pubmed: 26869608
Clin Cancer Res. 2010 Sep 1;16(17):4363-73
pubmed: 20651055
Nucleic Acids Res. 2016 Jul 8;44(W1):W90-7
pubmed: 27141961
Proc Natl Acad Sci U S A. 2013 Nov 5;110(45):18042-51
pubmed: 24058167
Differentiation. 2014 Mar-Apr;87(3-4):119-26
pubmed: 24830354
Genes Dev. 2001 Dec 15;15(24):3243-8
pubmed: 11751630
Science. 2016 Apr 8;352(6282):189-96
pubmed: 27124452
Mol Cell Biol. 2011 Jul;31(14):3052-67
pubmed: 21606196
Cell Stem Cell. 2020 Apr 2;26(4):593-608.e8
pubmed: 32004478
PLoS One. 2012;7(12):e53817
pubmed: 23285300
EMBO J. 2019 Jun 17;38(12):
pubmed: 31028085
Genome Biol. 2015 Dec 10;16:278
pubmed: 26653891
Sci Transl Med. 2018 Jun 20;10(446):
pubmed: 29925636
Proc Natl Acad Sci U S A. 2017 Apr 11;114(15):3903-3908
pubmed: 28351980
Nat Commun. 2017 Apr 07;8:14922
pubmed: 28387316
Nat Med. 2015 Mar;21(3):256-62
pubmed: 25706875

Auteurs

Antonella F M Dost (AFM)

Stem Cell Program and Divisions of Hematology/Oncology and Pulmonary Medicine, Boston Children's Hospital, Boston, MA 02115, USA; Harvard Stem Cell Institute, Cambridge, MA 02138, USA; Department of Genetics, Harvard Medical School, Boston, MA 02115, USA.

Aaron L Moye (AL)

Stem Cell Program and Divisions of Hematology/Oncology and Pulmonary Medicine, Boston Children's Hospital, Boston, MA 02115, USA; Harvard Stem Cell Institute, Cambridge, MA 02138, USA; Department of Genetics, Harvard Medical School, Boston, MA 02115, USA.

Marall Vedaie (M)

Center for Regenerative Medicine of Boston University and Boston Medical Center, Boston, MA 02118, USA; The Pulmonary Center and Department of Medicine, Boston University School of Medicine, Boston, MA 02118, USA.

Linh M Tran (LM)

Department of Medicine, David Geffen School of Medicine at UCLA, University of California, Los Angeles, Los Angeles, CA, USA.

Eileen Fung (E)

Department of Surgery, David Geffen School of Medicine at UCLA, University of California, Los Angeles, Los Angeles, CA, USA.

Dar Heinze (D)

Center for Regenerative Medicine of Boston University and Boston Medical Center, Boston, MA 02118, USA; Section of Gastroenterology and Department of Medicine, Boston University School of Medicine, Boston, MA 02118, USA.

Carlos Villacorta-Martin (C)

Center for Regenerative Medicine of Boston University and Boston Medical Center, Boston, MA 02118, USA.

Jessie Huang (J)

Center for Regenerative Medicine of Boston University and Boston Medical Center, Boston, MA 02118, USA; The Pulmonary Center and Department of Medicine, Boston University School of Medicine, Boston, MA 02118, USA.

Ryan Hekman (R)

Center for Network Systems Biology, Boston University, Boston, MA 02118, USA; Department of Biochemistry, Boston University School of Medicine, Boston, MA 02118, USA.

Julian H Kwan (JH)

Center for Network Systems Biology, Boston University, Boston, MA 02118, USA; Department of Biochemistry, Boston University School of Medicine, Boston, MA 02118, USA.

Benjamin C Blum (BC)

Center for Network Systems Biology, Boston University, Boston, MA 02118, USA; Department of Biochemistry, Boston University School of Medicine, Boston, MA 02118, USA.

Sharon M Louie (SM)

Stem Cell Program and Divisions of Hematology/Oncology and Pulmonary Medicine, Boston Children's Hospital, Boston, MA 02115, USA; Harvard Stem Cell Institute, Cambridge, MA 02138, USA; Department of Genetics, Harvard Medical School, Boston, MA 02115, USA.

Samuel P Rowbotham (SP)

Stem Cell Program and Divisions of Hematology/Oncology and Pulmonary Medicine, Boston Children's Hospital, Boston, MA 02115, USA; Harvard Stem Cell Institute, Cambridge, MA 02138, USA; Department of Genetics, Harvard Medical School, Boston, MA 02115, USA.

Julio Sainz de Aja (J)

Stem Cell Program and Divisions of Hematology/Oncology and Pulmonary Medicine, Boston Children's Hospital, Boston, MA 02115, USA; Harvard Stem Cell Institute, Cambridge, MA 02138, USA; Department of Genetics, Harvard Medical School, Boston, MA 02115, USA.

Mary E Piper (ME)

Harvard T.H. Chan School of Public Health, Department of Biostatistics, Boston, MA 02115, USA.

Preetida J Bhetariya (PJ)

Stem Cell Program and Divisions of Hematology/Oncology and Pulmonary Medicine, Boston Children's Hospital, Boston, MA 02115, USA; Harvard Stem Cell Institute, Cambridge, MA 02138, USA; Department of Genetics, Harvard Medical School, Boston, MA 02115, USA; Harvard T.H. Chan School of Public Health, Department of Biostatistics, Boston, MA 02115, USA.

Roderick T Bronson (RT)

Rodent Histopathology Core, Harvard Medical School, Boston, MA 02115, USA.

Andrew Emili (A)

Center for Network Systems Biology, Boston University, Boston, MA 02118, USA; Department of Biochemistry, Boston University School of Medicine, Boston, MA 02118, USA; Department of Biology, Boston University, Boston, MA 02215, USA.

Gustavo Mostoslavsky (G)

Center for Regenerative Medicine of Boston University and Boston Medical Center, Boston, MA 02118, USA; Section of Gastroenterology and Department of Medicine, Boston University School of Medicine, Boston, MA 02118, USA.

Gregory A Fishbein (GA)

Department of Pathology and Laboratory Medicine, David Geffen School of Medicine at UCLA, University of California, Los Angeles, Los Angeles, CA 90095, USA.

William D Wallace (WD)

Department of Pathology and Laboratory Medicine, David Geffen School of Medicine at UCLA, University of California, Los Angeles, Los Angeles, CA 90095, USA; Department of Pathology, Keck School of Medicine of USC, University of Southern California, Los Angeles, CA 90033, USA.

Kostyantyn Krysan (K)

Department of Medicine, David Geffen School of Medicine at UCLA, University of California, Los Angeles, Los Angeles, CA, USA.

Steven M Dubinett (SM)

Department of Medicine, David Geffen School of Medicine at UCLA, University of California, Los Angeles, Los Angeles, CA, USA; Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles, CA 90095, USA.

Jane Yanagawa (J)

Department of Surgery, David Geffen School of Medicine at UCLA, University of California, Los Angeles, Los Angeles, CA, USA; Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles, CA 90095, USA. Electronic address: jyanagawa@mednet.ucla.edu.

Darrell N Kotton (DN)

Center for Regenerative Medicine of Boston University and Boston Medical Center, Boston, MA 02118, USA; The Pulmonary Center and Department of Medicine, Boston University School of Medicine, Boston, MA 02118, USA. Electronic address: dkotton@bu.edu.

Carla F Kim (CF)

Stem Cell Program and Divisions of Hematology/Oncology and Pulmonary Medicine, Boston Children's Hospital, Boston, MA 02115, USA; Harvard Stem Cell Institute, Cambridge, MA 02138, USA; Department of Genetics, Harvard Medical School, Boston, MA 02115, USA. Electronic address: carla.kim@childrens.harvard.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH